4//SEC Filing
Curran Terrie 4
Accession 0002065881-25-000025
CIK 0001787306other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:17 PM ET
Size
364.4 KB
Accession
0002065881-25-000025
Insider Transaction Report
Form 4
Curran Terrie
Director
Transactions
- Award
Common Stock
2025-06-12+7,609→ 17,748 total - Award
Stock Option (right to buy)
2025-06-12+20,568→ 20,568 totalExercise: $13.50Exp: 2035-06-12→ Common Stock (20,568 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on December 16, 2024, maintained by the Company.
- [F2]The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001690298
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 8:17 PM ET
- Size
- 364.4 KB